Markets:

Overview

News

Currencies

International

Treasuries

Forma Therapeutics Holdings, Inc. - Common Stock (NQ:FMTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 13, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Forma Therapeutics Holdings, Inc. - Common Stock

< Previous 1 2 3 Next >

Biotech Stocks Well-Positioned For The Fourth Quarter ↗

October 12, 2022

The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.

Via Talk Markets

Novo Nordisk Touts Another Once-Weekly Insulin Icodec Win In Type 2 Diabetes ↗

October 03, 2022

Via Benzinga

Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease

September 30, 2022

From Forma Therapeutics, Inc.

Via Business Wire

FORMA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX

September 27, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

4 Analysts Have This to Say About Forma Therapeutics Hldgs ↗

September 02, 2022

Within the last quarter, Forma Therapeutics Hldgs (NASDAQ:FMTX) has observed the following analyst ratings:

Via Benzinga

Recap: Forma Therapeutics Q2 Earnings ↗

August 05, 2022

Forma Therapeutics Hldgs (NASDAQ:FMTX) reported its Q2 earnings results on Friday, August 5, 2022 at 07:05 AM. Here's what investors need to know about the announcement.

Via Benzinga

Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗

September 15, 2022

The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.

Via Investor's Business Daily

Top Russell 2000 Stocks: Trading Opportunities For Next Week - Sunday, Sept. 11 ↗

September 11, 2022

A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some Russell 2000 stock...

Via Talk Markets

FORMA THERAPEUTICS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX

September 02, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022 ↗

September 02, 2022

Via Benzinga

This Analyst Predicts $700 For Broadcom, Plus RBC Capital Slashes PT On This Stock By 85% ↗

September 02, 2022

Keybanc cut the price target for Broadcom Inc. (NASDAQ: AVGO) from $780 to $700. Broadcom shares rose 2.3% to $503.14 in pre-market trading.

Via Benzinga

Dow Turns Higher; Gold Down 1% ↗

September 01, 2022

U.S. stocks pared losses, with the Dow Jones turning higher toward the end of trading on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 01, 2022

Via Benzinga

Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday ↗

September 02, 2022

Gainers

Via Benzinga

Nasdaq Tumbles 250 Points; Crude Oil Falls Sharply ↗

September 01, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 250 points on Thursday

Via Benzinga

Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session ↗

September 01, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split.

Via Benzinga

Novo Nordisk Jumps Into Sickle Cell Fray With $1.1 Billion Forma Therapeutics Buyout ↗

September 01, 2022

The deal helps beef up Novo's early-stage efforts in sickle cell disease.

Via Investor's Business Daily

Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday ↗

September 01, 2022

Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) jumped 48.5% to $19.90 after Novo Nordisk announced it will acquire the company for $20 per share in cash.

Via Benzinga

Guardforce AI (GFAI) Stock Gets a Boost From New Exec Team ↗

September 01, 2022

Guardforce AI (GFAI) stock is climbing higher on Thursday after announcing a new executive team that will lead the company.

Via InvestorPlace

Forma Therapeutics (FMTX) Stock Soars on Novo Nordisk Acquisition News ↗

September 01, 2022

There's a major pharmaceutical market deal afoot -- and it's worth over $1 billion -- so FMTX stock is heading higher on the news.

Via InvestorPlace

After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal ↗

September 01, 2022

Via Benzinga

FMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Forma Therapeutics, Holdings Inc. Is Fair to Shareholders

September 01, 2022

From Halper Sadeh LLP

Via Business Wire

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

September 01, 2022

From Forma Therapeutics

Via Business Wire

Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

August 05, 2022

From Forma Therapeutics Holdings, Inc.

Via Business Wire

Earnings Scheduled For August 5, 2022 ↗

August 05, 2022

Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.

Via Benzinga

Earnings Outlook For Forma Therapeutics Hldgs ↗

August 04, 2022

Forma Therapeutics Hldgs (NASDAQ:FMTX) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗

August 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Rigel Pharma Expands Blood Cancer Portfolio With Forma Therapeutics Licensing Pact ↗

August 03, 2022

Via Benzinga

Forma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022

July 29, 2022

From Forma Therapeutics Holdings, Inc.

Via Business Wire

Forma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

July 12, 2022

From Forma Therapeutics Holdings, Inc.

Via Business Wire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.